RoActemra (tocilizumab) - Important Safety Information from Roche Products (Ireland) Ltd as approved by HPRA

Notice type: 3rd Party Publications

Date: 28/06/2019

 

Problem Or Issue:
Important Safety Information from Roche Products (Ireland) Ltd on RoActemra (tocilizumab) : Rare risk of serious hepatic injury including acute liver failure requiring transplantation

Important Safety Information - RoActemra (tocilizumab)


« Back